389 EGF-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic oxygen compounds | 96 | 29.8 | 3.22× | q < 0.0001 | |
| Homogeneous metal compounds | 79 | 73.6 | 1.07× | q = 0.50 | |
| Homogeneous non-metal compounds | 30 | 32.3 | 0.93× | q = 0.83 | |
| Organic acids and derivatives | 4 | 23.2 | 0.17× | q < 0.0001 | |
| Nucleosides, nucleotides, and analogues | 5 | 41.4 | 0.12× | q < 0.0001 | |
| Benzenoids | 1 | 11.0 | 0.09× | q = 6.7e-4 | |
| Organoheterocyclic compounds | 2 | 23.1 | 0.09× | q < 0.0001 | |
| Lipids and lipid-like molecules | 0 | 16.7 | 0 | q < 0.0001 | |
| Organic nitrogen compounds | 4 | 4.8 | 0.84× | not tested | |
| Organosulfur compounds | 1 | 3.1 | 0.32× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 476 |
| DB04473 | FUC | alpha-L-fucose | 57 |
| DB02379 | BGC | Beta-D-Glucose | 44 |
| DB01593 | — | — | 36 |
| DB14487 | — | — | 36 |
| DB09130 | — | — | 28 |
| DB08818 | — | — | 24 |
| DB14533 | — | — | 24 |
| DB12010 | — | Fostamatinib | 16 |
| DB11973 | — | — | 10 |
| DB12843 | — | — | 9 |
| DB00364 | — | — | 8 |
| DB03721 | — | N-acetyl-alpha-neuraminic acid | 8 |
| DB04454 | — | Alpha-Aminobutyric Acid | 8 |
| DB09332 | — | — | 8 |
| DB01050 | — | — | 7 |
| DB09213 | — | Dexibuprofen | 7 |
| DB02709 | — | Resveratrol | 6 |
| DB03017 | — | Lauric acid | 6 |
| DB12267 | — | Brigatinib | 6 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 706 |
| CAmetal | CALCIUM ION | 603 |
| CL | CHLORIDE ION | 76 |
| FUC | alpha-L-fucopyranose | 67 |
| BGC | beta-D-glucopyranose | 58 |
| ZNmetal | ZINC ION | 23 |
| NAmetal | SODIUM ION | 21 |
| MNmetal | MANGANESE (II) ION | 17 |
| GLC | alpha-D-glucopyranose | 12 |
| CDmetal | CADMIUM ION | 10 |
| MGmetal | MAGNESIUM ION | 9 |
| NGA | 2-acetamido-2-deoxy-beta-D-galactopyranose | 8 |
| COmetal | COBALT (II) ION | 7 |
| CUmetal | COPPER (II) ION | 7 |
| AKG | 2-OXOGLUTARIC ACID | 6 |
| IOD | IODIDE ION | 6 |
| MRD | (4R)-2-METHYLPENTANE-2,4-DIOL | 6 |
| Kmetal | POTASSIUM ION | 5 |
| BAmetal | BARIUM ION | 4 |
| FEmetal | FE (III) ION | 4 |